Structured evidence table for Zinc Pms Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Zinc Pms Randomized Trial | Some evidence suggests that women with Rh-negative blood type may have a higher likelihood of developing premenstrual symptoms, although mechanistic explanations remain speculative and findings are not yet consistent across studies. | 4 | Martire Francesco Giuseppe (2026) | Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications |
| Zinc Pms Randomized Trial | High caffeine intake has also been linked to increased PMS risk, possibly through its impact on sleep quality, anxiety, and neuroendocrine regulation. | 4 | Martire Francesco Giuseppe (2026) | Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications |
| Zinc Pms Randomized Trial | 13 3 14 15 16 17 18 19 20 13 21 22 23 13 13 3 22 The etiopathogenesis of PMS and PMDD is multifactorial and remains only partially understood, but current evidence indicates that symptoms arise from a complex interplay between normal ovarian steroid fluctuations and an underlying neurobiological vulnerability present only in susceptible individuals. | 4 | Martire Francesco Giuseppe (2026) | Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications |
| Zinc Pms Randomized Trial | 1 2 3 4 5 6 Premenstrual syndrome is a gynaecological and psychiatric disorder that reduces the quality of life of affected patients []. | 4 | Martire Francesco Giuseppe (2026) | Premenstrual Syndrome and Nutritional Factors: A Narrative Review of Current Evidence and Clinical Implications |
| Zinc Pms Randomized Trial | PMD significantly impacts the overall health and well-being of women, contributing to higher levels of depression, anxiety, suicidal risk, impaired social and educational/work performance, and lower quality of life [,,–]. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Zinc Pms Randomized Trial | It is estimated that 10% of women with PMDD have bipolar disorder, which poses a 7-fold higher risk compared to women without PMDD []. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Zinc Pms Randomized Trial | Estrogens promote serotonergic transmission by upregulating the expression of the rate-limiting enzyme tryptophan hydroxylase (TPH), thereby increasing tryptophan levels (which is necessary for 5-HT synthesis) and downregulating the expression of the serotonin transporter (SERT), resulting in increased availability of 5-HT in the synaptic cleft [,]. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
| Zinc Pms Randomized Trial | 1 1 2 3 1 1 4 Premenstrual symptoms refer to both psychological and somatic distress that present in the luteal phase of the menstrual cycle []. | 4 | Krupa Anna Julia (2025) | Zinc, copper, and magnesium in premenstrual disorders: a narrative review |
Source documents